I have spoken about mesotherapy in the past and the fact that it is still not an approved procedure in the United States. It does not mean, though, that you cannot have it. That is why the American Society for Aesthetic Plastic Surgery (ASAPS) has announced the commencement of a double-blind placebo study of mesotherapy.
Recommended links: Mesotherapy to cure cellulite
Mesotherapy, which is known in the United States as the “fat dissolving” treatment Lipodissolve, involves the injection of various compounds into the skin. However, the absence of proper protocols and regulation of mesotherapy may put patients at risk. The goal of the ASAPS’ clinical trial is to give physicians and their patients more specific and standardized protocols for the use of mesotherapy as well as a basis for understanding the risks and possible benefit of this reported fat dissolving treatment.
Developed as a separate medical specialty in France in 1952, mesotherapy is a controversial method of breaking down fat cells, or in common language, “melting fat.” The procedure has gained recognition in America through advertising and its use for weight loss purposes by celebrities.
Patients seeking fat dissolving treatments should be educated about the lack of clinical data to support these treatments and cautioned to wait until there is reliable information to guide their decision. Patients should also be warned about seeking treatments from people who may not be qualified to administer the large numbers of injections, which require very precise placement, involved in mesotherapy. Many mesotherapy treatment centers are opening around the country. These treatment centers are not necessarily staffed by knowledgeable and fully-trained professionals.
According to the 2005 Aesthetic Society Cosmetic Surgery Statistics, mesotherapy was performed last year on 4,773 Americans. This is the first year statistics on this procedure were collected.